OneAscent Investment Solutions’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
OneAscent Investment Solutions's BMY Position: Q1 2026 in Review
OneAscent Investment Solutions increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q1 2026, buying an estimated $4.66K and bringing the position to 6,677 shares worth $405K. The position accounts for 0.41% of the portfolio, ranked #65.
OneAscent Investment Solutions first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $432K in Q2 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- OneAscent Investment Solutions held 6,677 shares of Bristol-Myers Squibb worth $405K as of Q1 2026.
- OneAscent Investment Solutions bought 80 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.66K.
- Bristol-Myers Squibb made up 0.41% of OneAscent Investment Solutions's portfolio in Q1 2026, its #65 holding.
- OneAscent Investment Solutions first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
- OneAscent Investment Solutions's Bristol-Myers Squibb position peaked at $432K in Q2 2025.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on OneAscent Investment Solutions's 13F filing for Q1 2026, filed 29 Apr 2026.